Language: Français

Human T-Cell Lymphotropic Virus (HTLV)

 Human T-Cell Lymphotropic Virus (HTLV) (9823-08) Learn about the characteristics, worldwide seroprevalence, transmission and diseases associated with these human retroviruses and discover how detection has impacted transfusion medicine.

Code 9823-08
Level Advanced

Member Price


Non-Member Price



Additional Details

PEP hours: 11
CPS credits: 0.8
Level: Advanced
Course Type: Express

Start Date: Upon registration
Completion: Up to 52 weeks
Delivery: PDF via email

Prerequisites: None
Textbook: N/A
Equipment: Computer with Internet is required

Learning Outcomes:

  • Describe the discovery of the Human T-Cell Lymphotropic Viruses
  • Characterize the HTLV virus: family, viral structure, and genomic structure
  • Give details of the reported worldwide seroprevalence of HTLV
  • Discuss the factors that influence seroprevalence in the community
  • Identify the problems of getting an accurate picture of the worldwide distribution of HTLV
  • Describe the modes of transmission of the virus
  • List the diseases associated with the HTLV viruses
  • Describe the transfusion transmitted infection
  • Describe the rationale for screening blood donors for HTLV antibody status
  • Give details of the transfusion transmission rates and the factors affecting transmission
  • Describe the testing methods used to screen for the presence of the viruses
  • Describe the testing methods available to confirm the screening assay results
  • Discuss the findings of published method evaluations
  • Describe the approach to the management and treatment of patients seropositive for HTLV

Author/Instructor: John Chapman, FCSMLS, FIMLS, CLSp(H)
Version Date: March 2008